Paper Details

  1. Home
  2. Paper Details

Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.

Author: , AlonsoGuillermo, FerrarisJorge R, GalichAna M, JasperHéctor, LegalSusana, PasqualiniTitania, SorrochePatricia

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Deflazacort therapy, compared to methylprednisone, may improve linear growth and lean body mass, prevent excessive bone loss and fat accumulation, and improve lipoprotein profile without reducing insulin sensitivity in prepubertal patients after kidney transplantation.
Paper Details　
Original Abstract of the Article :
Metabolic effects of deflazacort vs. methylprednisone were studied in prepubertal patients after kidney transplantation. Thirty-one patients participated: 15 received deflazacort and 16 remained on methylprednisone. The study started at a mean of 2.1 years after transplantation, when patients were r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00467-006-0403-0

データ提供：米国国立医学図書館（NLM）

Effects of Deflazacort vs. Methylprednisone: A Randomized Study in Kidney Transplant Patients

This research, like a careful gardener tending to a delicate plant, compares the effects of two medications, deflazacort and methylprednisone, in kidney transplant patients. The study investigates the metabolic effects of these drugs on prepubertal patients, evaluating their impact on growth, body composition, and bone mineral density. The findings provide valuable insights into the optimal choice of medication for kidney transplant patients, aiming to minimize potential side effects and maximize long-term health outcomes.

Finding the Right Balance: Comparing Medications for Kidney Transplant Patients

This research, like a desert explorer seeking the most suitable oasis, compares the effects of two medications, deflazacort and methylprednisone, in kidney transplant patients. The study investigates the metabolic effects of these drugs, evaluating their impact on growth, body composition, and bone mineral density. The findings offer valuable insights into the optimal choice of medication for kidney transplant patients, ensuring effective treatment while minimizing potential side effects.

Long-Term Health: Optimizing Treatment for Kidney Transplant Patients

This research, like a wise camel navigating a long and arduous journey, explores the effects of two medications, deflazacort and methylprednisone, in kidney transplant patients. The study investigates the metabolic effects of these drugs, evaluating their impact on growth, body composition, and bone mineral density. The findings provide valuable insights into the optimal choice of medication for kidney transplant patients, aiming to minimize potential side effects and maximize long-term health outcomes. This research highlights the importance of considering long-term health consequences when choosing medication for kidney transplant patients.

Dr. Camel's Conclusion

This research, like a camel navigating the vast desert of kidney transplant medicine, compares the effects of two medications, deflazacort and methylprednisone, in kidney transplant patients. The study investigates the metabolic effects of these drugs, evaluating their impact on growth, body composition, and bone mineral density. The findings offer valuable insights into the optimal choice of medication for kidney transplant patients, ensuring effective treatment while minimizing potential side effects and maximizing long-term health outcomes.
Date :
  1. Date Completed 2007-07-23
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

17294225

DOI: Digital Object Identifier

10.1007/s00467-006-0403-0

Related Literature

Article Analysis
・Effects of deflazacort
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.